Zahra Madjd
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 20
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 9
- Oncology top 1%
- Cancer Cells and Metastasis 55
- Immunology top 2%
- Immunotherapy and Immune Responses 20
- Molecular Biology top 5%
- Renal and related cancers 21
- Epigenetics and DNA Methylation 14
- Cell Biology top 5%
-
- Monoclonal and Polyclonal Antibodies Research 10
- Co-authors
- Ian O. EllisIan SpendloveLindy G. DurrantRaheleh RoudiMojgan AsgariAhmad ShariftabriziMaryam AbolhasaniNicholas FS Watson
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Cancer Cell International (8 papers)Cancer Biomarkers (7 papers)Scientific Reports (5 papers)
- Partner nations
- IranUnited StatesCanada
In The Last Decade
Zahra Madjd
163 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 124
- Cancer Research 931
- Oncology 1.7k
- Immunology 1.0k
- Molecular Biology 1.9k
- Cell Biology 247
Countries citing papers authored by Zahra Madjd
This map shows the geographic impact of Zahra Madjd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zahra Madjd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zahra Madjd more than expected).
Fields of papers citing papers by Zahra Madjd
This network shows the impact of papers produced by Zahra Madjd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zahra Madjd. The network helps show where Zahra Madjd may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zahra Madjd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 17 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 16 | |
| 9 | 2019 | 17 | |
| 10 | 2019 | 29 | |
| 11 | 2017 | 39 | |
| 12 | 2015 | 16 | |
| 13 | 2013 | 40 | |
| 14 | EXPRESSION OF BRCA1 PROTEIN IN INVASIVE AND IN SITU CARCINOMAS AND ITS RELATION WITH MARKER OF BREAST CANCER STEM CELLS (CD44) AND PROGNOSTIC FACTORS IN BREAST CANCER PATIENTS | 2010 | 0 |
| 15 | OCT-4, an Embryonic Stem Cell Marker Expressed in Breast, Brain and Thyroid Carcinomas Compared to Testicular Carcinoma | 2009 | 2 |
| 16 | The need for palliative care services in Iran; an introductory commentary | 2008 | 10 |
| 17 | Spiritual care at the end of life in the Islamic context, a systematic review | 2008 | 12 |
| 18 | Gaps in the provision of spiritual care for terminally ill patients in Islamic societies — a systematic review | 2008 | 9 |
| 19 | Prognostic significance of SC101, a monoclonal Antibody against Lewisy/b in breast tumors | 2005 | 0 |
| 20 | Total Loss of MHC Class I is an Independent Indicator of Good Prognosis in Breast Cancer | 2005 | 5 |
About Zahra Madjd
Zahra Madjd is a scholar working on Oncology, Cancer Research and Immunology, having authored 174 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (55 papers), Renal and related cancers (21 papers), Cancer Genomics and Diagnostics (20 papers), Immunotherapy and Immune Responses (20 papers), Epigenetics and DNA Methylation (14 papers), Cancer-related molecular mechanisms research (10 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and MicroRNA in disease regulation (9 papers). The work is most often cited by research in Cancer Research (931 citations), Oncology (1.7k citations) and Immunology (1.0k citations). Zahra Madjd has collaborated with scholars based in Iran, United States and Canada. Frequent co-authors include Ian O. Ellis, Ian Spendlove, Lindy G. Durrant, Raheleh Roudi, Mojgan Asgari, Ahmad Shariftabrizi, Maryam Abolhasani, Nicholas FS Watson, Leili Saeednejad Zanjani and J H Scholefield. Their work appears in journals such as Cancer Cell International, Cancer Biomarkers, Scientific Reports, Journal of Cancer Research and Clinical Oncology and Experimental and Molecular Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.